Pediatrix Medical Group, Inc.
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $165.4M | $-99.1M | $-60.4M | $66.3M | $131.0M | $-796.5M | $-1.50B | $268.6M |
| Depreciation & Amortization | $21.8M | $32.2M | $36.2M | $35.6M | $32.1M | $28.4M | $25.9M | $24.4M |
| Depreciation | $14.3M | $22.7M | $28.1M | $26.7M | $21.6M | $19.3M | $18.7M | $17.8M |
| Amortization | $5.7M | $7.1M | $5.6M | $6.4M | $8.0M | $7.6M | $7.3M | $6.8M |
| Stock-Based Compensation | $18.0M | $11.9M | $12.3M | $16.1M | $19.0M | $39.0M | $33.4M | $36.6M |
| Net Cash from Operating Activities | $271.1M | $206.6M | $137.3M | $166.9M | $76.7M | $204.6M | $357.7M | $313.7M |
| Investing Activities | ||||||||
| Capital Expenditures | $18.5M | $22.0M | $33.3M | $29.7M | $32.2M | $28.8M | $19.3M | $17.1M |
| Business Acquisitions | $23.2M | $8.2M | $6.7M | $28.2M | $29.9M | $2.2M | $-47.0M | $65.4M |
| Net Cash from Investing Activities | $-18.3M | $-35.4M | $-48.2M | $-57.0M | $-53.1M | $815.5M | $102.5M | $-142.8M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | $86.7M | $1.7M | $919.0K | $88.5M | $4.7M | $8.5M | $145.3M | $302.2M |
| Net Cash from Financing Activities | $-107.5M | $-14.5M | $-25.7M | $-487.6M | $-760.1M | $-4.2M | $-393.1M | $-170.6M |
| Net Change in Cash | $145.3M | $156.7M | $63.4M | $-377.6M | $-736.5M | $1.02B | $67.1M | $329.0K |
| Free Cash Flow | $252.6M | $184.6M | $104.0M | $137.2M | $44.5M | $175.8M | $338.4M | $296.6M |